Markets:

Overview

News

Currencies

International

Treasuries

Clearmind Medicine Inc. - Common Shares (NQ:CMND)

0.8481 -0.2919 (-25.61%)

Streaming Delayed Price Updated: 12:41 PM EDT, Apr 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clearmind Medicine Inc. - Common Shares

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Clearmind Medicine Stock Is Soaring: What's Going On? ↗

January 10, 2024

Via Benzinga

Dow Surges 100 Points; PriceSmart Earnings Top Views ↗

January 10, 2024

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.27% to 37,627.83 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Why Is Clearmind (CMND) Stock Up 40% Today? ↗

January 10, 2024

The jump in Clearmind sent its market cap to $6 million. The study of psychedelic compounds to treat mental illness is growing.

Via InvestorPlace

Clearmind Medicine Completed Type A Meeting with the FDA

January 10, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More ↗

January 07, 2024

Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury

Via Benzinga

SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments

January 04, 2024

From SciSparc Ltd

Via GlobeNewswire

Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments

January 04, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More ↗

December 27, 2023

President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also...

Via Benzinga

Psyched: Biden's Big Decision On Psychedelics Therapy; LSD Anxiety Results; Matthew Perry Autopsy And More ↗

December 18, 2023

Biden To Decide On Psychedelic Therapy Bill

Via Benzinga

Clearmind Medicine Announces It Is In Compliance with All Applicable Nasdaq Listing Standards

December 14, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 12, 2023

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket ↗

December 12, 2023

Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 12, 2023

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

Via InvestorPlace

Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More ↗

December 11, 2023

John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy

Via Benzinga

Crude Oil Moves Lower; AutoZone Profit Tops Views ↗

December 05, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on Tuesday. The Dow traded down 0.18% to 36,138.19 while the NASDAQ rose 0.19% to 14,212.19. The S&P 500...

Via Benzinga

Topics Stocks

Why Is Clearmind Medicine (CMND) Stock Up 50% Today? ↗

December 05, 2023

Psychedelic-medicine specialist Clearmind Medicine posted encouraging study results, leading to a significant boost in CMND stock.

Via InvestorPlace

Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 05, 2023

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

Via Benzinga

Dow Falls 100 Points; ISM Services PMI Increases In November ↗

December 05, 2023

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Tuesday. The Dow traded down 0.28% to 36,103.52 while the NASDAQ rose 0.32% to 14,230.64. The S&P...

Via Benzinga

Topics Stocks

Why Clearmind Stock Is Climbing Higher Tuesday ↗

December 05, 2023

Clearmind Medicine Inc (NYSE: CMND) shares are trading higher Tuesday after the company announced results in its cocaine addiction treatment.

Via Benzinga

Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More ↗

December 05, 2023

Defense Dept. Funds Ketamine Study For PTSD Treatment

Via Benzinga

Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment

December 05, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial

December 01, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 30, 2023

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.

Via Benzinga

Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

November 30, 2023

Shares of Salesforce, Inc.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 30, 2023

It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 29, 2023

Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning!

Via InvestorPlace

Why Clearmind Medicine Stock Is Moving Today ↗

November 28, 2023

Clearmind Medicine Inc. (NASDAQ: CMND) shares are trading higher on Tuesday after the company announced results from its weight loss and metabol

Via Benzinga

Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based Treatment

November 28, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

EXCLUSIVE: Clearmind Medicine's Psychedelic-Based Treatment Shows Encouraging Preclinical Activity In Obesity, Metabolic Disorders ↗

November 28, 2023

Clearmind Medicine Inc (NASDAQ: CMND) has released results from its pre-clinical trial of the combination therapy.

Via Benzinga

Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures

November 27, 2023

From Clearmind Medicine Inc.

Via GlobeNewswire

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.